Novel targeted system to deliver chemotherapeutic drugs to EphA2-expressing cancer cells.

Journal of Medicinal Chemistry
Si WangMaurizio Pellecchia

Abstract

The efficacy of anticancer drugs is often limited by their systemic toxicities and adverse side effects. We report that the EphA2 receptor is overexpressed preferentially in several human cancer cell lines compared to normal tissues and that an EphA2 targeting peptide (YSAYPDSVPMMS) can be effective in delivering anticancer agents to such tumors. Hence, we report on the synthesis and characterizations of a novel EphA2-targeting agent conjugated with the chemotherapeutic drug paclitaxel. We found that the peptide-drug conjugate is dramatically more effective than paclitaxel alone at inhibiting tumor growth in a prostate cancer xenograft model, delivering significantly higher levels of drug to the tumor site. We believe these studies open the way to the development of a new class of therapeutic compounds that exploit the EphA2 receptor for drug delivery to cancer cells.

References

Sep 28, 1990·Science·R Langer
Apr 16, 1982·Science·J L Marx
Mar 17, 1997·Biochemical and Biophysical Research Communications·G M GersukR L Vessella
Aug 3, 1999·Nature Biotechnology·E KoivunenR Pasqualini
Feb 15, 2001·Seminars in Cancer Biology·E Ruoslahti
Jul 4, 2001·Angewandte Chemie·Hartmuth C. KolbK. Barry Sharpless
Jun 8, 2002·Nature Medicine·Pirjo LaakkonenErkki Ruoslahti
Sep 28, 2002·The Journal of Biological Chemistry·Mitchell KoolpeElena B Pasquale
May 17, 2005·Current Cancer Drug Targets·Reneé C Ireton, Jin Chen
Jun 16, 2005·Bioorganic & Medicinal Chemistry·Stanislav JaraczIwao Ojima
Aug 6, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Meri M VihantoUyen Huynh-Do
Aug 16, 2005·Cancer Cell·Madhu MacraeFrank McCormick
Sep 10, 2005·Nature Biotechnology·Anna M Wu, Peter D Senter
Oct 1, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·David M MutchGary Williamson
Nov 23, 2005·Expert Opinion on Therapeutic Targets·Charles N LandenAnil K Sood
Jan 21, 2006·Nature Reviews. Drug Discovery·David SchramaJürgen C Becker
Mar 2, 2006·Expert Opinion on Drug Delivery·Lilian E van Vlerken, Mansoor M Amiji
Mar 7, 2006·Biochemical and Biophysical Research Communications·Brian P FoxRaj P Kandpal
Aug 4, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Weibo CaiXiaoyuan Chen
Sep 21, 2007·Molecular Pharmaceutics·Olulanu H AinaKit S Lam
Dec 20, 2007·Molecular Cancer Therapeutics·Jill WykoskyWaldemar Debinski
Dec 22, 2007·Nature Reviews. Drug Discovery·Benjamin LeaderDavid E Golan
Jul 10, 2008·Journal of the American Chemical Society·Kenneth E ScarberryZ John Zhang
Jul 10, 2008·Bioconjugate Chemistry·Geoffrey von MaltzahnSangeeta N Bhatia
Sep 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wanhua YangDing Ma
Nov 18, 2008·Cancer Research·Dowdy JacksonDavid A Tice
Dec 17, 2008·Molecular Cancer Research : MCR·Jill Wykosky, Waldemar Debinski
Jan 23, 2009·Methods in Molecular Biology·Jessica R Newton, Susan L Deutscher
Feb 6, 2009·Molecular Biology of the Cell·Koichi MiuraHisataka Sabe
Apr 4, 2009·Bioconjugate Chemistry·William H BlackburnL Andrew Lyon
Dec 17, 2009·Critical Reviews in Therapeutic Drug Carrier Systems·Somnath Singh, Alekha K Dash
Feb 25, 2010·Nature Reviews. Cancer·Elena B Pasquale
Aug 4, 2010·Biochemistry·Sayantan MitraElena B Pasquale
Dec 15, 2010·Expert Opinion on Therapeutic Targets·Manish TandonSuresh K Mittal
Mar 5, 2011·Pharmaceutical Research·Stéphanie DeshayesGérard Déléris
Mar 10, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jeffry CutreraShulin Li
Apr 8, 2011·Current Pharmaceutical Biotechnology·Angelo Corti, Flavio Curnis
Aug 17, 2011·International Journal of Molecular Sciences·Yongjin LiuBing Yan
Sep 22, 2011·Current Cancer Drug Targets·Rong Biao-xueMing Zong-juan
Nov 3, 2011·Seminars in Cell & Developmental Biology·Roberta NoberiniElena B Pasquale
Nov 25, 2011·Proceedings of the National Academy of Sciences of the United States of America·Shingo HatakeyamaMichiko N Fukuda
Jan 21, 2012·Pharmacognosy Magazine·Jin-Won ChungSung-Jin Kim

❮ Previous
Next ❯

Citations

Mar 16, 2013·Journal of Medicinal Chemistry·Matteo IncertiAlessio Lodola
Nov 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Si WangMaurizio Pellecchia
Apr 29, 2014·Nuclear Medicine and Biology·Yu LiuRui An
May 29, 2014·Pharmaceutical Research·Apurva R PatelMandip Singh
Oct 11, 2014·Expert Opinion on Drug Delivery·Khadija RhodaViness Pillay
Jan 17, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Virginia J YaoRenata Pasqualini
Oct 23, 2015·Colloids and Surfaces. B, Biointerfaces·Xiangyang XieJianping Deng
Sep 14, 2015·European Journal of Medicinal Chemistry·Riccardo CastelliAlessio Lodola
Oct 9, 2014·Annual Review of Pharmacology and Toxicology·Antonio Barquilla, Elena B Pasquale
May 20, 2016·ACS Applied Materials & Interfaces·Man YingWeiyue Lu
Jun 10, 2016·Biochimica Et Biophysica Acta·Deo R SinghKalina Hristova
Nov 5, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Man YingWeiyue Lu
Mar 7, 2017·Acta Pharmacologica Sinica·Andrew G CheethamHonggang Cui
Apr 26, 2017·Bioconjugate Chemistry·Seren HamsiciMustafa O Guler
Mar 29, 2014·ChemMedChem·Elisa BarileMaurizio Pellecchia
Jul 26, 2018·Future Medicinal Chemistry·Theodora ChatzisideriVasiliki Sarli
Sep 30, 2014·Journal of Labelled Compounds & Radiopharmaceuticals·Marc PretzeConstantin Mamat
Jan 17, 2019·Nanoscale Research Letters·Xiaoying ZhouJie Li
Mar 22, 2020·Expert Opinion on Therapeutic Targets·Carmine GiorgioMassimiliano Tognolini
Apr 9, 2020·Cell Communication and Signaling : CCS·Roghayyeh BaghbanPeyman Zare
Aug 29, 2013·The Journal of Biological Chemistry·Jing HeWilliam C Wimley
Nov 9, 2018·International Journal of Molecular Sciences·Christin MöserDavid M Smith
Mar 25, 2019·Drug Delivery·Ningning SongJinhua Zhao
Jun 5, 2020·Pharmaceuticals·Robert M Hughes, Jitka A I Virag
May 17, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rongjun HeRichard D DiMarchi
Aug 20, 2020·Journal of Hematology & Oncology·Ta XiaoMin Su
Apr 25, 2019·The Journal of Biological Chemistry·Maricel Gomez-SolerElena B Pasquale
Sep 30, 2020·Molecular Biology Reports·Max London, Eugenio Gallo
May 14, 2020·Pharmaceuticals·Ahmed F SalemMaurizio Pellecchia
May 14, 2020·Molecular Cancer Therapeutics·Gavin BennettNicholas Keen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved